Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-22

Clinical Trial Update: HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity [Phase 1]

View source ↗

Summary

A Phase 1 trial testing whether adding fluvastatin and simvastatin to interferon can improve interferon sensitivity in chronic hepatitis C was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvastatin (fluvastatin)
  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Bader, Ted, M.D. | Conditions: Chronic Hepatitis C | Phase 1 | Status: TERMINATED